Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer

Background The first‐line treatment for squamous cell lung cancer (SCC) has not necessarily been established; however, our previous exploratory study suggested that the combination of nedaplatin and amrubicin would be a promising treatment approach for patients with SCC. Therefore, a phase II study...

Descrición completa

Detalles Bibliográficos

Principais autores:	Hirokazu Taniguchi, Hiroyuki Yamaguchi, Yosuke Dotsu, Midori Shimada, Hiroshi Gyotoku, Hiroaki Senju, Shinnosuke Takemoto, Takeshi Kitazaki, Masaaki Fukuda, Daiki Ogawara, Hiroshi Soda, Katsumi Nakatomi, Nanae Sugasaki, Akitoshi Kinoshita, Seiji Nagashima, Takaya Ikeda, Yoichi Nakamura, Noriho Sakamoto, Yasushi Obase, Minoru Fukuda, Hiroshi Mukae
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2019-09-01
Series:	Thoracic Cancer
Assuntos:	Amrubicin clinical trial nedaplatin squamous cell lung cancer
Acceso en liña:	https://doi.org/10.1111/1759-7714.13134
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!